Xue Gao

Rice University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

A point-of-care microfluidic device takes unprocessed clinical samples, actively lyses viral RNAs, and performs the target amplification-free nucleic acid detection with a limit of detection down to 10 aM with 25 min sample-to-result time.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Mitchell Miller

Rice University

UNITED STATES

View details

Hongzhi Zeng

Rice University

UNITED STATES

View details

Zheng Sun

Baylor College of Medicine

UNITED STATES

View details

Yi Zhang

University of Connecticut

UNITED STATES

View details

Sean A. Newmister

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xue Gao

Research Interests

Explore related searches

Contact this professor

Articles (19)

Correction to “Exploring Bioactive Fungal RiPPs: Advances, Challenges, and Future Prospects”

Enzymatic Ring Contraction for the Biosynthesis of Sulfur-Containing Cyclopentachromone

Recent advances in prime editing technologies and their promises for therapeutic applications

Exploring Bioactive Fungal RiPPs: Advances, Challenges, and Future Prospects

An NmrA-like enzyme-catalysed redox-mediated Diels-Alder cycloaddition with anti-selectivity.

A point-of-care microfluidic biosensing system for rapid and ultrasensitive nucleic acid detection from clinical samples

Fungal P450 Deconstructs the 2,5-Diazabicyclo[2.2.2]octane Ring <i>En Route</i> to the Complete Biosynthesis of 21<i>R</i>-Citrinadin A

A split and inducible adenine base editor for precise in vivo base editing

Revolutionizing genetic disease treatment: Recent technological advances in base editing

CRISPR-Cas12a Biosensor Array for Ultrasensitive Detection of Unamplified DNA with Single-Nucleotide Polymorphic Discrimination

Utilizing a cell-free protein synthesis platform for the biosynthesis of a natural product, caffeine.

Structural basis for the activation of a compact CRISPR-Cas13 nuclease

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Unraveling the biosynthesis of penicillenols by genome mining polyketide synthase and nonribosomal peptide synthetase gene clusters in Penicillium citrinum

Multiplex base- and prime-editing with drive-and-process CRISPR arrays

A general theoretical framework to design base editors with reduced bystander effects

Quinolactacin Biosynthesis Involves Non‐Ribosomal‐Peptide‐Synthetase‐Catalyzed Dieckmann Condensation to Form the Quinolone‐γ‐lactam Hybrid

Quinolactacin Biosynthesis Involves Non‐Ribosomal‐Peptide‐Synthetase‐Catalyzed Dieckmann Condensation to Form the Quinolone‐γ‐lactam Hybrid

A Dual-Plasmid CRISPR/Cas System for Mycotoxin Elimination in Polykaryotic Industrial Fungi

Collaborators (5)

Mitchell Miller

Hongzhi Zeng

Zheng Sun

Yi Zhang

Sean A. Newmister

Make your next move.